Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Recruiting now

Conditions studied: Hepatitis B, Acute-On-Chronic Liver Failure

In brief

This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.

Key facts

Study ID

NCT04310787

Run by

Third Affiliated Hospital, Sun Yat-Sen University

People needed

300

Starts

2020-05-15

Expected to finish

2024-12-31

Last updated by the study team

2024-11-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age from 18 to 65 years old;
• The diagnosis consistent with hepatitis b associated chronic acute liver failure；
• After hospitalization, the survival time > 90 days；
• The inpatient clinical data are complete.

You may not qualify if…

• Human immunodeficiency virus infection or congenital immune deficiency diseases;
• Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival;
• Other conditions that the researchers judged not appropriate for inclusion.

Where it is running

• Third Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.